Saltar al contenido

Jorge Barriuso

@drjorgebarriuso.bsky.social did:plc:la5yqfbrpcahwwqd3f75k4og

Consultant (clinician-scientist) in medical oncology with an interest in Lower GI malignancies including appendix tumours and peritoneal metastasis. #H12O #imas12 #rarecancers #translationalresearch #drugdevelopment

En Bluesky desde el

Seguidores
51
Siguiendo
17
Posts
28
Días en rankings
0

Resumen

Jorge Barriuso (@drjorgebarriuso.bsky.social) es un usuario de Bluesky que se unió el 25 noviembre 2024. Tiene 51 seguidores, sigue a 17 cuentas y ha publicado 28 posts.

Apariciones en rankings

Los mejores días en que los posts de esta cuenta entraron en la lista diaria de Debya.

Esta cuenta aún no ha aparecido en un ranking diario.

Posts que le gustaron recientemente

Me gusta públicos de la red Bluesky.

  • ESMO - European Society for Medical Oncology@myesmo.bsky.social

    #ESMO26: Changing the cytotoxic payload may help to overcome resistance to antibody–drug conjugates (#ADCs). Rachel Abelman discusses studies investigating this strategy to improve patient responses in #BreastCancer #InsightsbyESMO ➡️ https://ow.ly/96mf5100brC

    Ver post
  • ESMO - European Society for Medical Oncology@myesmo.bsky.social

    #ESMO26: Early-phase #ClinicalTrial results with the novel bispecific antibodies, pumitamig and opamtistomig, reflect a growing body of research in #NeuroendocrineCarcinoma #InsightsbyESMO ➡️ https://ow.ly/oxLC5100p7J #NENs #NECs #RareCancers

    Ver post
  • ESMO - European Society for Medical Oncology@myesmo.bsky.social

    👉 #ESMONovelTherapies27: Novel therapies are changing oncology. Are you ready to optimise them in practice? -Understand the science -Select the right patients -Navigate treatment sequencing -Manage toxicities 🔗 https://ow.ly/vIkz50ZZAHh

    Ver post
  • ESMO - European Society for Medical Oncology@myesmo.bsky.social

    #ESMO26: Preliminary data support encorafenib and cetuximab #rechallenge in metastatic colorectal cancer (#mCRC), although questions remain around patient selection and treatment specifications, as discussed by Rona Yaeger 🔗 https://ow.ly/6bmH5100p2M #InsightsbyESMO

    Ver post
  • ESMO - European Society for Medical Oncology@myesmo.bsky.social

    #ESMO26: Phase III PERSEE #ClinicalTrial reports a 44% reduction in the risk of progression or death with the addition of #chemotherapy to pembrolizumab versus pembrolizumab alone in first-line advanced #NSCLC with #PD-L1 ≥50% ➡️ https://ow.ly/eWmC5100p3O #InsightsbyESMO Alfredo Addeo

    Ver post

Inicia sesión para ver más

Cuentas que bloquea

En Bluesky los bloqueos son registros públicos.

Esta cuenta no bloquea a nadie.